CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Revenues:
Products	$ 185,561	$ 145,925	$ 277,150	$ 211,536
Monitoring and other related services	4,630,556	2,309,864	9,159,586	4,903,547
Total revenues	4,816,117	2,455,789	9,436,736	5,115,083
Cost of revenues:
Products	54,920	58,349	76,277	121,070
Monitoring and other related services	1,889,267	960,418	3,857,997	2,221,526
Impairment of monitoring equipment and parts (Note 4)	85,221	75,000	140,301	150,000
Total cost of revenues	2,029,408	1,093,767	4,074,575	2,492,596
Gross profit	2,786,709	1,362,022	5,362,161	2,622,487
Operating expenses:
Selling, general and administrative	4,674,824	2,564,015	8,414,505	4,735,423
Research and development	345,698	403,175	809,876	722,745
Loss from operations	(2,233,813)	(1,605,168)	(3,862,220)	(2,835,681)
Other income (expense):
Interest income	11,294	12,883	22,744	24,106
Interest expense	(644,655)	(327,367)	(1,328,596)	(371,285)
Currency exchange rate gain (loss)	(454,564)	2,803	(374,002)	(4,232)
Disgorgement funds received (Note 18)	4,700,000		4,700,000
Other income, net	9,028	624,730	14,329	624,780
Net income (loss)	1,387,470	(1,292,119)	(827,745)	(2,562,312)
Dividends on Series D Preferred stock		5,103		14,530
Net income (loss) attributable to common shareholders	1,387,470	(1,297,222)	(827,745)	(2,576,842)
Foreign currency translation adjustments	(177,896)		(804,774)
Comprehensive income (loss)	$ 1,209,574	$ 1,297,222	$ 1,632,519	$ 2,576,842
Net loss per common share, basic	$ 0.14	$ (0.13)	$ (0.08)	$ (0.26)
Net loss per common share, diluted	$ 0.14	$ (0.13)	$ (0.08)	$ (0.26)
Weighted average common shares outstanding, basic	10,144,000	9,830,000	10,126,000	9,819,000
Weighted average common shares outstanding, diluted	10,209,000	9,830,000	10,126,000	9,819,000